LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 13.78 | 771.67 | 1515 | 1459 | 1.0378 | 1.0824 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 16.00 | 771.67 | 1490 | 1585 | 0.9398 | 0.8839 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 16.00 | 771.67 | 1479 | 1585 | 0.9328 | 0.8705 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.22 | 771.67 | 1545 | 1741 | 0.8872 | 0.8062 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 18.22 | 771.67 | 1573 | 1741 | 0.9033 | 0.8341 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.44 | 771.67 | 1580 | 1910 | 0.8269 | 0.7295 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 20.44 | 771.67 | 1578 | 1910 | 0.8258 | 0.7278 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.66 | 771.67 | 1548 | 2141 | 0.7229 | 0.6044 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 22.66 | 771.67 | 1531 | 2141 | 0.7149 | 0.5924 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.89 | 771.67 | 1561 | 2397 | 0.6510 | 0.5384 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 24.89 | 771.67 | 1471 | 2397 | 0.6135 | 0.4835 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 27.11 | 771.67 | 1579 | 2675 | 0.5903 | 0.4906 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 27.11 | 771.67 | 1495 | 2675 | 0.5589 | 0.4459 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.33 | 771.67 | 1613 | 2939 | 0.5488 | 0.4654 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 29.33 | 771.67 | 1778 | 2939 | 0.6049 | 0.5413 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.55 | 771.67 | 1597 | 3196 | 0.4996 | 0.4258 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 31.55 | 771.67 | 1802 | 3196 | 0.5637 | 0.5122 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.78 | 771.67 | 1644 | 3499 | 0.4698 | 0.4145 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 33.78 | 771.67 | 1854 | 3499 | 0.5298 | 0.4946 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.00 | 771.67 | 1663 | 3884 | 0.4281 | 0.3900 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.00 | 771.67 | 1960 | 3884 | 0.5045 | 0.4915 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.22 | 771.67 | 1702 | 4299 | 0.3959 | 0.3760 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.22 | 771.67 | 1878 | 4299 | 0.4368 | 0.4318 | MN20160304_L01 | M14 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.44 | 771.67 | 1766 | 4738 | 0.3727 | 0.3719 | MN20160304_L01 | H06 |
MCF 10A-H2B-mCherry | Trametinib | 0.01 | 40.44 | 771.67 | 2127 | 4738 | 0.4489 | 0.4729 | MN20160304_L01 | M14 |